LABFF (Laboratorios Farmaceuticos Rovi) Cash per Share: $2.20 (As of Mar. 2026)

What is Laboratorios Farmaceuticos Rovi Cash per Share?

Laboratorios Farmaceuticos Rovi LABFF 93 Cash per Share is $2.20 as of Mar. 2026. GuruFocus rates LABFF with a GF Score™ of 93/100 and a GF Value™ of $82.42. The stock has 1 warning sign investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Laboratorios Farmaceuticos Rovi's Cash per Share for the quarter that ended in Mar. 2026 was $2.20.

Laboratorios Farmaceuticos Rovi (OTCPK:LABFF) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Laboratorios Farmaceuticos Rovi Cash per Share Related Terms

Laboratorios Farmaceuticos Rovi Cash per Share Historical Data

* Premium members only.

The historical data trend for Laboratorios Farmaceuticos Rovi's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Laboratorios Farmaceuticos Rovi Cash per Share Chart

Laboratorios Farmaceuticos Rovi Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Cash per Share

Get a 7-Day Free Trial

2.04

2.53

0.53

0.56

2.24

Laboratorios Farmaceuticos Rovi Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Cash per Share	Get a 7-Day Free Trial															0.62	1.07	1.13	2.24	2.20

93GF Score

Laboratorios Farmaceuticos Rovi SA LABFF

Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Laboratorios Farmaceuticos Rovi Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Laboratorios Farmaceuticos Rovi's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	114.726	/	51.1
	=	2.24

Laboratorios Farmaceuticos Rovi's Cash per Share for the quarter that ended in Mar. 2026 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	112.591	/	51.1
	=	2.20

Frequently Asked Questions Learn more about Cash per Share →

What does a Cash per Share of $2.20 mean?

Laboratorios Farmaceuticos Rovi (LABFF) has a Cash per Share of $2.20 as of Mar. 2026. Cash per share is the per-share value of a company's available cash. View historical data for Laboratorios Farmaceuticos Rovi and its competitors.

Is Laboratorios Farmaceuticos Rovi's Cash per Share too high?

Laboratorios Farmaceuticos Rovi's current Cash per Share is $2.20. Overall, Laboratorios Farmaceuticos Rovi has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.

How does Laboratorios Farmaceuticos Rovi's Cash per Share compare to ZTS and UTHR?

Laboratorios Farmaceuticos Rovi's Cash per Share of $2.20 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Cash per Share for a Drug Manufacturers company?

A good Cash per Share depends on the Drug Manufacturers industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Cash per Share mean?

A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Laboratorios Farmaceuticos Rovi and its competitors. Laboratorios Farmaceuticos Rovi's current Cash per Share is $2.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Laboratorios Farmaceuticos Rovi stock overvalued right now?

Laboratorios Farmaceuticos Rovi (LABFF) has a current Cash per Share of $2.20. The stock's GF Value™ is $82.42, compared to a current price of $90.61 — trading 9.9% above its estimated fair value. The current Cash per Share is $2.20. Laboratorios Farmaceuticos Rovi's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Cash per Share calculated?

Cash per Share is calculated from a company's financial statements. For Laboratorios Farmaceuticos Rovi (LABFF), the current Cash per Share is $2.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Laboratorios Farmaceuticos Rovi (LABFF) Overvalued in 2026?

Based on GuruFocus' analysis, Laboratorios Farmaceuticos Rovi stock appears to be overvalued. The current stock price of $90.61 is trading 9.9% above its estimated GF Value™ of $82.42.

Key valuation signals for LABFF:

Cash per Share: $2.20
GF Value™: $82.42 vs. price of $90.61 (9.9% above fair value)
GF Score™: 93/100 with 1 warning sign

No single metric tells the full story. See the LABFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Laboratorios Farmaceuticos Rovi Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies XMAD:ALM XMAD:FAE XMAD:RJF XMAD:LAB XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR HKSE:03692 VTRS NSE:DIVISLAB OSTO:SOBI NBIX NSE:TORNTPHARM

Other Exchanges ROVIN:Mexico 1ROVI:Italy ROVIe:UK 0ILL:UK ROVI:Spain 41L:Germany ROVI:Austria

Address Julian Camarillo, 35, Madrid, ESP, 28037

Website https://www.rovi.es

Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.

93GF Score

Get the complete analysis for LABFF

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$90.61

Price

$82.42

GF Value

View LABFF Analysis

See Cash per Share data for all stocks →